{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:15:18Z","timestamp":1791281718965,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T00:00:00Z","timestamp":1374192000000},"content-version":"vor","delay-in-days":1356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["1805"],"award-info":[{"award-number":["1805"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007077","name":"National Institute of Biomedical Innovation","doi-asserted-by":"publisher","award":["09-15"],"award-info":[{"award-number":["09-15"]}],"id":[{"id":"10.13039\/501100007077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18390303"],"award-info":[{"award-number":["18390303"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.ajhg.2009.09.016","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T04:27:02Z","timestamp":1256272022000},"page":"569-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Use of a Modified \u03b1-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease"],"prefix":"10.1016","volume":"85","author":[{"given":"Youichi","family":"Tajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsukimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayasu","family":"Togawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Jigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Fukushige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kanekura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toya","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajhg.2009.09.016_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"alpha-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.ajhg.2009.09.016_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2009.09.016_bib3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: Pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2009.09.016_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ajhg.2009.09.016_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","article-title":"Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease","volume":"97","author":"Schiffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2009.09.016_bib6","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3469","article-title":"I-cell disease and pseudo-Hurler polydystrophy: Disorders of lysosomal enzyme phosphorylation and localization","author":"Kornfeld","year":"2001"},{"key":"10.1016\/j.ajhg.2009.09.016_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10038-005-0342-9","article-title":"Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice","volume":"51","author":"Sakuraba","year":"2006","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2009.09.016_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2007.06.013","article-title":"Influence of antibody formation on reduction of globotriaosylceramide (GL-3) in urine from Fabry patients during agalsidase beta therapy","volume":"92","author":"Ohashi","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ajhg.2009.09.016_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2008.03.008","article-title":"Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease","volume":"94","author":"Ohashi","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ajhg.2009.09.016_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2008.03.003","article-title":"Treatment of Fabry disease with different dosing regimens of agalsidase: Effects on antibody formation and GL-3","volume":"94","author":"Vedder","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ajhg.2009.09.016_bib11","series-title":"Practical Enzymology of the Sphingolipidoses","first-page":"173","article-title":"Fabry disease: \u03b1-galactosidase A deficiency","author":"Dean","year":"1977"},{"key":"10.1016\/j.ajhg.2009.09.016_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/prot.10550","article-title":"Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling","volume":"53","author":"Petrey","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.ajhg.2009.09.016_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0969-2126(02)00726-8","article-title":"The 1.9 \u00c5 structure of \u03b1-N-acetylgalactosaminidase: Molecular basis of glycosidase deficiency diseases","volume":"10","author":"Garman","year":"2002","journal-title":"Structure"},{"key":"10.1016\/j.ajhg.2009.09.016_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: Structure of human alpha-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ajhg.2009.09.016_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jcc.540160702","article-title":"Accurate modeling of the intramolecular electrostatic energy of proteins","volume":"16","author":"Dudek","year":"1995","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ajhg.2009.09.016_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1063\/1.474409","article-title":"Calculation of the reaction field due to off-center point multipoles","volume":"107","author":"Kong","year":"1997","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ajhg.2009.09.016_bib17","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1021\/jp982255t","article-title":"Analysis and application of potential energy smoothing for global optimization","volume":"102","author":"Pappu","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ajhg.2009.09.016_bib18","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1021\/jp027815+","article-title":"Polarizable atomic multipole water model for molecular mechanics simulation","volume":"107","author":"Ren","year":"2003","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ajhg.2009.09.016_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal \u03b1-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ajhg.2009.09.016_bib20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0006-291X(91)91678-6","article-title":"Biosynthesis of human \u03b1-N-acetylgalactosaminidase: Defective phosphorylation and maturation in infantile \u03b1-NAGA deficiency","volume":"175","author":"Hu","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ajhg.2009.09.016_bib21","doi-asserted-by":"crossref","first-page":"13567","DOI":"10.1073\/pnas.1834876100","article-title":"Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation","volume":"100","author":"Akagi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2009.09.016_bib22","series-title":"Current Protocols in Immunology","first-page":"10.17.14","article-title":"Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems","author":"Swift","year":"2001"},{"key":"10.1016\/j.ajhg.2009.09.016_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1006\/bbrc.1995.2416","article-title":"Galactose stabilizes various missense mutants of \u03b1-galactosidase in Fabry disease","volume":"214","author":"Okumiya","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ajhg.2009.09.016_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10038-006-0369-6","article-title":"Corrective effect on Fabry mice of yeast recombinant human \u03b1-galactosidase with N-linked sugar chains suitable for lysosomal delivery","volume":"51","author":"Sakuraba","year":"2006","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2009.09.016_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2008.12.017","article-title":"Molecular interaction of imino sugars with human alpha-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease","volume":"96","author":"Sugawara","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ajhg.2009.09.016_bib26","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1177\/0091270007305299","article-title":"Enzyme replacement in Fabry disease: Pharmacokinetics and pharmacodynamics of agalsidase alfa in children and adolescents","volume":"47","author":"Ries","year":"2007","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ajhg.2009.09.016_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/abbi.1994.1144","article-title":"Generation of one set of murine monoclonal antibodies specific for globo-series glycolipids: Evidence for differential distribution of the glycolipids in rat small intestine","volume":"310","author":"Kotani","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ajhg.2009.09.016_bib28","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"alpha-Galactosidase A deficient mice: A model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2009.09.016_bib29","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","article-title":"Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice","volume":"96","author":"Ohshima","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2009.09.016_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: Preclinical studies demonstrate the effectiveness of \u03b1-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2009.09.016_bib31","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.222221899","article-title":"Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer","volume":"99","author":"Takahashi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2009.09.016_bib32","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1523-1755.2004.00924.x","article-title":"Enzyme therapy for Fabry disease: Neutralizing antibodies toward agalsidase alpha and beta","volume":"66","author":"Linthorst","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.ajhg.2009.09.016_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/GIM.0b013e318170f868","article-title":"Successful reinstitution of agalsidase beta therapy in Fabry disease patients with previous IgE-antibody or skin-test reactivity to the recombinant enzyme","volume":"10","author":"Bodensteiner","year":"2008","journal-title":"Genet. Med."},{"key":"10.1016\/j.ajhg.2009.09.016_bib34","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3483","article-title":"alpha-N-Acetylgalactosaminidase deficiency: Schindler disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.ajhg.2009.09.016_bib35","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1016\/S0021-9258(19)44613-9","article-title":"Purification and properties of human alpha-galactosidases","volume":"247","author":"Beutler","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ajhg.2009.09.016_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0005-2744(77)90361-8","article-title":"The identity of alpha-galactosidase B from human liver","volume":"482","author":"Schram","year":"1977","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ajhg.2009.09.016_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/glycob\/10.3.251","article-title":"Human \u03b1-N-acetylgalactosaminidase: Site occupancy and structure of N-linked oligosaccharide","volume":"10","author":"Ohta","year":"2000","journal-title":"Glycobiology"},{"key":"10.1016\/j.ajhg.2009.09.016_bib38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/glycob\/cwf096","article-title":"Production in yeast of \u03b1-galactosidase A, a lysosomal enzyme applicable to enzyme replacement therapy for Fabry disease","volume":"12","author":"Chiba","year":"2002","journal-title":"Glycobiology"},{"key":"10.1016\/j.ajhg.2009.09.016_bib39","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s10038-007-0210-x","article-title":"Establishment of immortalized Schwann cells from Fabry mice and their low uptake of recombinant \u03b1-galactosidase","volume":"52","author":"Kawashima","year":"2007","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2009.09.016_bib40","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3371","article-title":"Sphingolipid activator proteins","author":"Sandhoff","year":"2001"}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929709004121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929709004121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:15:17Z","timestamp":1762078517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929709004121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0002929709004121"],"URL":"https:\/\/doi.org\/10.1016\/j.ajhg.2009.09.016","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a Modified \u03b1-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajhg.2009.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}